BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 28363996)

  • 1.
    Jiang L; Hermeking H
    Cancer Res; 2017 May; 77(10):2746-2758. PubMed ID: 28363996
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Liu F; Bouznad N; Kaller M; Shi X; König J; Jaeckel S; Hermeking H
    Int J Biol Sci; 2022; 18(14):5415-5437. PubMed ID: 36147476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas9-mediated inactivation of miR-34a and miR-34b/c in HCT116 colorectal cancer cells: comprehensive characterization after exposure to 5-FU reveals EMT and autophagy as key processes regulated by miR-34.
    Huang Z; Kaller M; Hermeking H
    Cell Death Differ; 2023 Aug; 30(8):2017-2034. PubMed ID: 37488217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cluster microRNAs miR-194 and miR-215 suppress the tumorigenicity of intestinal tumor organoids.
    Nakaoka T; Saito Y; Shimamoto Y; Muramatsu T; Kimura M; Kanai Y; Saito H
    Cancer Sci; 2017 Apr; 108(4):678-684. PubMed ID: 28092415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms.
    Joosten SPJ; Zeilstra J; van Andel H; Mijnals RC; Zaunbrecher J; Duivenvoorden AAM; van de Wetering M; Clevers H; Spaargaren M; Pals ST
    Gastroenterology; 2017 Oct; 153(4):1040-1053.e4. PubMed ID: 28716720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin activates a ROS/KEAP1/NRF2/miR-34a/b/c cascade to suppress colorectal cancer metastasis.
    Liu C; Rokavec M; Huang Z; Hermeking H
    Cell Death Differ; 2023 Jul; 30(7):1771-1785. PubMed ID: 37210578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stromal Indian hedgehog signaling is required for intestinal adenoma formation in mice.
    Büller NV; Rosekrans SL; Metcalfe C; Heijmans J; van Dop WA; Fessler E; Jansen M; Ahn C; Vermeulen JL; Westendorp BF; Robanus-Maandag EC; Offerhaus GJ; Medema JP; D'Haens GR; Wildenberg ME; de Sauvage FJ; Muncan V; van den Brink GR
    Gastroenterology; 2015 Jan; 148(1):170-180.e6. PubMed ID: 25307863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal epithelial cell-specific CD98 expression regulates tumorigenesis in Apc(Min/+) mice.
    Nguyen HT; Dalmasso G; Yan Y; Laroui H; Charania M; Ingersoll S; Ayyadurai S; Zhang Y; Sitaraman S; Merlin D
    Lab Invest; 2012 Aug; 92(8):1203-12. PubMed ID: 22641098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas.
    Vogt M; Munding J; Grüner M; Liffers ST; Verdoodt B; Hauk J; Steinstraesser L; Tannapfel A; Hermeking H
    Virchows Arch; 2011 Mar; 458(3):313-22. PubMed ID: 21225432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis.
    Zeilstra J; Joosten SP; Dokter M; Verwiel E; Spaargaren M; Pals ST
    Cancer Res; 2008 May; 68(10):3655-61. PubMed ID: 18483247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-34a and miR-34b/c have distinct effects on the suppression of lung adenocarcinomas.
    Kim JS; Kim EJ; Lee S; Tan X; Liu X; Park S; Kang K; Yoon JS; Ko YH; Kurie JM; Ahn YH
    Exp Mol Med; 2019 Jan; 51(1):1-10. PubMed ID: 30700696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased microRNA-34b and -34c predominantly expressed in stromal tissues is associated with poor prognosis in human colon cancer.
    Hiyoshi Y; Schetter AJ; Okayama H; Inamura K; Anami K; Nguyen GH; Horikawa I; Hawkes JE; Bowman ED; Leung SY; Harris CC
    PLoS One; 2015; 10(4):e0124899. PubMed ID: 25894979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer.
    Zhang Y; Guo L; Li Y; Feng GH; Teng F; Li W; Zhou Q
    Mol Cancer; 2018 Jan; 17(1):1. PubMed ID: 29304823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Axl-Regulating Tumor Suppressor miR-34a Is Increased in ccRCC but Does Not Correlate with Axl mRNA or Axl Protein Levels.
    Fritz HK; Gustafsson A; Ljungberg B; Ceder Y; Axelson H; Dahlbäck B
    PLoS One; 2015; 10(8):e0135991. PubMed ID: 26287733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperation between the thyroid hormone receptor TRalpha1 and the WNT pathway in the induction of intestinal tumorigenesis.
    Kress E; Skah S; Sirakov M; Nadjar J; Gadot N; Scoazec JY; Samarut J; Plateroti M
    Gastroenterology; 2010 May; 138(5):1863-74. PubMed ID: 20114049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ap4 is rate limiting for intestinal tumor formation by controlling the homeostasis of intestinal stem cells.
    Jaeckel S; Kaller M; Jackstadt R; Götz U; Müller S; Boos S; Horst D; Jung P; Hermeking H
    Nat Commun; 2018 Sep; 9(1):3573. PubMed ID: 30177706
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Winter M; Rokavec M; Hermeking H
    Cancer Res; 2021 Jul; 81(13):3621-3634. PubMed ID: 34224368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of R-Spondin 1 in Apc
    Lähde M; Heino S; Högström J; Kaijalainen S; Anisimov A; Flanagan D; Kallio P; Leppänen VM; Ristimäki A; Ritvos O; Wu K; Tammela T; Hodder M; Sansom OJ; Alitalo K
    Gastroenterology; 2021 Jan; 160(1):245-259. PubMed ID: 32941878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Troy, a tumor necrosis factor receptor family member, interacts with lgr5 to inhibit wnt signaling in intestinal stem cells.
    Fafilek B; Krausova M; Vojtechova M; Pospichalova V; Tumova L; Sloncova E; Huranova M; Stancikova J; Hlavata A; Svec J; Sedlacek R; Luksan O; Oliverius M; Voska L; Jirsa M; Paces J; Kolar M; Krivjanska M; Klimesova K; Tlaskalova-Hogenova H; Korinek V
    Gastroenterology; 2013 Feb; 144(2):381-391. PubMed ID: 23142137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.